Animas Corporation, a fully-integrated global company within the Johnson & Johnson family of companies, is an innovator in insulin pump technology, with products such as the OneTouch® Ping™ glucose management system. We're experiencing an unprecedented period of strong double-digit growth, outpacing the rapid market growth in the insulin delivery category.
As part of the Johnson & Johnson Diabetes Franchise, the company's mission is to create a world without limits for people with diabetes.
At Animas, we're dedicated to making diabetes management easier through product innovation, exceptional customer support and customized education programs. Our goal is to improve the lifestyle of our patients, reduce the long-term effects of the disease, and lower healthcare costs.